Research Topics
Species | Keltouma DriouchSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumorsKeltouma Driouch
INSERM E 0017 Oncogénétique, Centre Rene Huguenin, 35 rue Dailly, F 92211 St Cloud, France
Oncogene 21:1832-40. 2002..Furthermore, identification of two distinct alternative WWOX transcripts expressed at high levels in human tumors suggests an involvement of the WWOX gene in breast cancer progression...
Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasisKeltouma Driouch
Centre Rene Huguenin, FNCLCC, INSERM U735, Saint Cloud, France
Clin Exp Metastasis 24:575-85. 2007..Here we review the major studies that had important impacts on the understanding of breast cancer metastasis. We also discuss the future challenges in this research field and the special issues that still need to be examined...
Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expressionIvan Bieche
Laboratoire d Oncogénétique INSERM E0017, Centre Rene Huguenin, St Cloud, France
Carcinogenesis 25:405-11. 2004..Taken together, the data confirm the role of the PEA3 gene in breast tumorigenesis, and suggest the existence of numerous other still unknown genes transactivated by the PEA3 transcription factor...
Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasisSoraya Sin
Institut Curie, Laboratoire d oncogénétique, Hôpital René Huguenin, 35 rue Dailly, Saint Cloud, 92210, France
J Natl Cancer Inst 103:1323-37. 2011..However, the possible role of kindlin-1 in cancer remains unknown...
A six-gene signature predicting breast cancer lung metastasisThomas Landemaine
Centre Rene Huguenin, Fédération Nationale des Centres de Lutte Contre le Cancer and Institut National de la Sante et de la Recherche Medicale, U735, Saint Cloud, France
Cancer Res 68:6092-9. 2008..Finally, we show that the signature improves risk stratification independently of known standard clinical variables and a previously established lung metastasis signature based on an experimental breast cancer metastasis model...
Prognostic value of ERBB family mRNA expression in breast carcinomasIvan Bieche
Laboratoire d Oncogénétique INSERM E0017, Centre Rene Huguenin, St Cloud, France
Int J Cancer 106:758-65. 2003....
Evidence of chromosome regions and gene involvement in inflammatory breast cancerFlorence Lerebours
Inserm E0017 oncogénétique, St Cloud, France
Int J Cancer 102:618-22. 2002..In contrast, the DNA amplification levels of ERBB2, MYC and CCND1, as measured by real-time quantitative PCR, did not differ between IBC and non IBC...
PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroupsMagdalena Cizkova
Laboratoire d oncogénétique, Institut Curie, Hôpital René Huguenin, 35 rue Dailly, Saint Cloud, F 92210, France
Breast Cancer Res 14:R28. 2012..PIK3CA is the oncogene showing the highest frequency of gain-of-function mutations in breast cancer, but the prognostic value of PIK3CA mutation status is controversial...
A methodological approach to unravel organ-specific breast cancer metastasisSebastien Nola
Institut Curie, Hôpital René Huguenin, Laboratoire d oncogénétique, 35 rue Dailly, Saint Cloud, France
J Mammary Gland Biol Neoplasia 17:135-45. 2012..This methodology can be considered as a useful workflow to identify and validate the genes that trigger and support organ tropism of breast cancer cells during metastasis...
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidyIvan Bieche
INSERM U735, Institut Curie Hôpital René Huguenin, St Cloud, France
Mol Cancer 10:23. 2011..Alterations of the mitotic spindle checkpoint are likely to contribute to these phenotypes, but little is known about somatic alterations of mitotic spindle checkpoint genes in breast cancer...
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancerJeroen T Buijs
Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Cancer Res 67:8742-51. 2007..Because exogenous BMP7 can still counteract the breast cancer growth at the primary site and in bone, BMP7 may represent a novel therapeutic molecule for repression of local and bone metastatic growth of breast cancer...
Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasisRebeca Sanz
Centre d Oncologia Molecular, Institut de Recerca Oncològica IDIBELL, Hospital Duran i Reynals, Gran Via, S N, Km 2 7, L Hospitalet Ll, 08907, Barcelona, Spain
Clin Exp Metastasis 24:673-83. 2007....
